# Birmex Advances 2027 Medicine Tender in Mexico

Mexico's federal health agency Birmex is preparing to award its consolidated medicine tender for 2027–2028, covering 657 product codes, signaling a major procurement event for pharmaceutical suppliers and medical device contractors. This tender follows ongoing efforts to streamline drug registration processes through collaboration with Brazil's Anvisa regulatory agency, aiming to expedite approvals and harmonize sanitary standards. Public health institutions such as ISSSTE and IMSS are also enhancing care delivery by integrating advanced technologies and AI-driven research, creating expanded opportunities for vendors specializing in clinical research, medical devices, and health technology solutions.

- The Birmex tender award on September 25, 2026, represents a significant procurement opportunity for pharmaceutical manufacturers and suppliers targeting the Mexican public health market.
- The new drug registration pathway leveraging Anvisa's regulatory framework may reduce time-to-market for medicines, benefiting companies with cross-border regulatory expertise.
- Integration of AI and curated data in pharmaceutical R&D indicates growing demand for technology providers and contractors supporting innovation in health services.
- Procurement professionals should consider the evolving regulatory environment and technology adoption trends when planning bids and partnerships in Mexico's health sector.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Regulatory Compliance, Artificial Intelligence
**Published:** September 24, 2026

### Government Entities
- Birmex
- COFEPRIS
- Anvisa
- ISSSTE
- IMSS

### Vendors
- Anthropic (prime contractor)
- Sanofi ()
- Medtronic ()
- Dräger Mexico ()
- AbbVie ()

### Key Quotes
> Medical care comes first, and administrative registration comes after.
> — Héctor Hurtado, Director, Ignacio Zaragoza Regional Hospital

> We want to move increasingly toward reciprocity and common sanitary and regulatory rules.
> — Alexandre Padilha, Minister of Health, Brazil

> Mexico should treat health spending as an investment in development, not a cost to minimize.
> — Sergio Vargas, General Manager, AbbVie

### Sources
- [The Week in Health: Birmex Tender, Anvisa Pathway, and AI R&D](https://mexicobusiness.news/health/news/week-health-birmex-tender-anvisa-pathway-and-ai-rd) - Mexico Business News